Skip to main content
OpenTrials
Completed

NCT Number: NCT02337816

Role of Metabolomics in the Diagnosis of Endometriosis

Endometriosis is one of the most common benign gynecological, affecting about 10% of premenopausal women. The pathophysiology of this disease is still not completely clear. Despite its prevalence, there is no blood test available for the diagnosis of endometriosis and the average delay time to diagnosis is 9.4 years.

Metabolomics is a scientific discipline that studies changes in metabolites related to the pathophysiology of the disease.

Aim of the study is to identify an alteration in the expression of the metabolites in women with endometriosis

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women of childbearing age ;
  • written consent to laparoscopic surgery;
  • written consent to the study .

Exclusion criteria

  • Suspicion or diagnosis of malignant disease
  • Inability or unwillingness to provide written consent

Treatment and study plan

laparoscopic surgery, obtainment of biological samples

Procedure

Primary outcomes

  1. Plasma and urine concentration of metabolites

    Time frame: At least one month after discontinuation of hormonal therapies , before laparoscopic surgery

Sponsors and collaborators

Lead sponsor

University of Cagliari

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jan 14, 2015
Registry last updated
Nov 6, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.